Literature DB >> 17239047

Psychiatric comorbidity and gender difference among treatment-seeking heroin abusers in Taiwan.

Shu-Chuan Chiang1, Hung-Yu Chan, Yuan-Ying Chang, Hsiao-Ju Sun, Wei J Chen, Chih-Ken Chen.   

Abstract

The objectives of the present study were to estimate the psychiatric comorbidity of Taiwanese heroin users seeking treatment and to identify the gender differences in psychiatric comorbidity and drug use behavior. Subjects were interviewed using a structured questionnaire on drug use behavior and the Mini International Neuropsychiatric Interview for psychiatric disorders. Of the subjects, 58.5% of the male and 62.5% of the female subjects had at least one non-substance-use axis I psychiatric disorder or antisocial personality disorder. Compared to male subjects, female subjects were younger, were less educated, had higher rates of unemployment and had earlier onset of illicit drug use. Female subjects were 11-fold more likely than male subjects to exhibit suicidal behavior. Among heroin abusers in the present study, female subjects were more widely exposed to unfavorable social factors and had substantially higher incidence of suicidal behavior than male subjects. Drug treatment centers should be aware of these gender differences and pay particular attention to comorbid depressive disorders and suicidal behavior of female heroin abusers.

Entities:  

Mesh:

Year:  2007        PMID: 17239047     DOI: 10.1111/j.1440-1819.2007.01618.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  17 in total

1.  Sex differences amongst dependent heroin users: histories, clinical characteristics and predictors of other substance dependence.

Authors:  Fiona L Shand; Louisa Degenhardt; Tim Slade; Elliot C Nelson
Journal:  Addict Behav       Date:  2010-08-10       Impact factor: 3.913

2.  Individual and Network Correlates of Antisocial Personality Disorder Among Rural Nonmedical Prescription Opioid Users.

Authors:  Rachel V Smith; April M Young; Ursula L Mullins; Jennifer R Havens
Journal:  J Rural Health       Date:  2016-05-12       Impact factor: 4.333

3.  Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women.

Authors:  Margaret M Benningfield; Amelia M Arria; Karol Kaltenbach; Sarah H Heil; Susan M Stine; Mara G Coyle; Gabriele Fischer; Hendrée E Jones; Peter R Martin
Journal:  Am J Addict       Date:  2010 Sep-Oct

4.  Psychopharmacologic management of opioid-dependent women during pregnancy.

Authors:  Peter R Martin; Amelia M Arria; Gabriele Fischer; Karol Kaltenbach; Sarah H Heil; Susan M Stine; Mara G Coyle; Peter Selby; Hendrée E Jones
Journal:  Am J Addict       Date:  2009 Mar-Apr

5.  Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes.

Authors:  Margaret M Benningfield; Mary S Dietrich; Hendrée E Jones; Karol Kaltenbach; Sarah H Heil; Susan M Stine; Mara G Coyle; Amelia M Arria; Kevin E O'Grady; Gabriele Fischer; Peter R Martin
Journal:  Addiction       Date:  2012-11       Impact factor: 6.526

6.  Effects of sex and remifentanil dose on rats' acquisition of responding for a remifentanil-conditioned reinforcer.

Authors:  Jeremiah W Bertz; Emily L Jackson; Davina R Barron; James H Woods
Journal:  Behav Pharmacol       Date:  2016-04       Impact factor: 2.293

7.  Clinical characteristics and risk behavior as a function of HIV status among heroin users enrolled in methadone treatment in northern Taiwan.

Authors:  Tony Szu-Hsien Lee; Hsi-Che Shen; Wei-Hsin Wu; Chun-Wei Huang; Muh-Yong Yen; Bo-En Wang; Peing Chuang; Chien-Yu Shih; Ying-Chun Chou; Yi-Lien Liu
Journal:  Subst Abuse Treat Prev Policy       Date:  2011-04-08

8.  Is there a gender difference in associates of adolescents' lifetime illicit drug use in Tehran, Iran?

Authors:  Katayoon Khooshabi; Setareh- Ameneh-Forouzan; Akhgar Ghassabian; Shervin Assari
Journal:  Arch Med Sci       Date:  2010-06-30       Impact factor: 3.318

9.  Personality Disorders, Narcotics, and Stimulants; Relationship in Iranian Male Substance Dependents Population.

Authors:  Simasadat Noorbakhsh; Zahra Zeinodini; Zeynab Khanjani; Hamid Poorsharifi; Sepideh Rajezi Esfahani
Journal:  Iran Red Crescent Med J       Date:  2015-06-23       Impact factor: 0.611

10.  First-time admissions for opioid treatment: cross-sectional and descriptive study of new opioid users seeking treatment.

Authors:  Gerardo Flórez; Ana López-Durán; Yolanda Triñanes; Jesús Osorio; Jaime Fraga; José Manuel Fernández; Elisardo Becoña; Manuel Arrojo
Journal:  Neuropsychiatr Dis Treat       Date:  2015-09-24       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.